Effect of minocycline on the left ventricular function following ST-elevation myocardial infarction treated by...

Area of Science:

• Cardiology
• Pharmacology

Background:

• Cardiac remodeling is a pathological process after myocardial infarction.
• Early intervention strategies are crucial for managing post-myocardial infarction cardiac dysfunction.
• Minocycline, an antibiotic, has shown anti-inflammatory properties that may impact cardiac remodeling.

Purpose of the Study:

• To investigate the effect of early short-term minocycline administration on left ventricular function and cardiac remodeling.
• To assess changes in matrix metalloproteinase-9 (MMP-9) levels as a biomarker of cardiac remodeling.
• To evaluate the impact of minocycline on echocardiographic parameters post-ST-elevation myocardial infarction (STEMI).

Main Methods:

• A double-blind, randomized controlled trial involving 73 STEMI patients undergoing primary percutaneous coronary intervention (PCI).
• Patients received either minocycline (50 mg daily for 5 days) or a placebo.
• Measurements included serum MMP-9 levels and 2-dimensional speckle tracking echocardiography at baseline and 4-6 months post-discharge.

Main Results:

• No significant differences in baseline characteristics between the minocycline and placebo groups.
• Serum MMP-9 levels remained unchanged within groups and showed no significant difference between groups post-intervention.
• Follow-up echocardiography revealed no significant differences in left ventricular function or remodeling between the two groups.

Conclusions:

• Early short-term minocycline treatment did not demonstrate a beneficial effect on cardiac remodeling.
• Minocycline did not significantly alter MMP-9 levels or improve left ventricular function in STEMI patients.
• Further research may be needed to explore different dosages, durations, or patient populations for minocycline's potential cardiac effects.